Rizio, Avery A.
Bhor, Menaka
Lin, Xiaochen
McCausland, Kristen L.
White, Michelle K.
Paulose, Jincy
Nandal, Savita
Halloway, Rashid I.
Bronté-Hall, Lanetta
Funding for this research was provided by:
Novartis Pharmaceuticals Corporation
Article History
Accepted: 31 December 2019
First Online: 13 January 2020
Compliance with ethical standards
:
: AAR, XL, KLM, and MKW are full-time employees of Optum and received research funding from Novartis Pharmaceuticals Corporation to conduct the study. MB, JP, and SN are full-time employees of the study sponsor, Novartis Pharmaceuticals Corporation; MB and JP also own stock in the company. LBH has received funding from the study sponsor, Novartis Pharmaceuticals Corporation, and from Bluebird Bio and Pfizer Inc. RH has nothing to disclose.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
: The informed consent form, protocol, and recruitment materials were approved by the New England Independent Review Board (IRB # 120180240). All participants provided consent.